MDM4 and breast cancer: Our findings showed a strong association between the MDM4-GA genotype and increased breast cancer patient susceptibility in the codominant model, with OR = 2.08 (CI = 1.1509–3.771), RR = 1.48 (1.0492–2.0918), and p = 0.015.